A second Sandoz biosimilar has been accepted for review by US FDA setting the stage for another potential legal battle with Amgen.
Biologic drugs will be given a minimum of five years of data protection under the TPP trade deal agreed today, upsetting industry groups which had campaigned for 12.
The £38m ($58m) National Biologics Manufacturing Centre has opened its doors offering bioprocessing space to SMEs in the UK.
Austin Community College has received a Government grant to establish a centre for biotechnology technicians it hopes will provide skilled workers for the Texas biomanufacturing industry.
CRO PRA Health Sciences is working with trial site group AMR for better vaccine studies and shorter development times.